ABOS
Acumen Pharmaceuticals (ABOS)
$33
About Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Details
Daily high
$2.42
Daily low
$2.31
Price at open
$2.42
52 Week High
$5.09
52 Week Low
$1.81
Market cap
143.6M
Dividend yield
0.00%
Volume
78,983
Avg. volume
164,103
P/E ratio
-2.14
Acumen Pharmaceuticals News
Details
Daily high
$2.42
Daily low
$2.31
Price at open
$2.42
52 Week High
$5.09
52 Week Low
$1.81
Market cap
143.6M
Dividend yield
0.00%
Volume
78,983
Avg. volume
164,103
P/E ratio
-2.14